Advances in the biology and treatment of myeloma

Progression free survival of myeloma patients who become IFE-negative correlates with the detection of residual monoclonal free light chain (FLC) by mass spectrometry.

Blood cancer journal·2024

Combination of flow cytometry and functional imaging for monitoring of residual disease in myeloma.

Leukemia·2018

Spatial genomic heterogeneity in multiple myeloma revealed by multi-region sequencing.

Nature communications·2017

Carfilzomib resistance due to ABCB1/MDR1 overexpression is overcome by nelfinavir and lopinavir in multiple myeloma.

Leukemia·2017

Prediction of outcome in newly diagnosed myeloma: a meta-analysis of the molecular profiles of 1905 trial patients.

Leukemia·2017

Overexpression of EZH2 in multiple myeloma is associated with poor prognosis and dysregulation of cell cycle control.

Blood cancer journal·2017

Outcome heterogeneity in CALR-mutated myeloproliferative neoplasms.

British journal of haematology·2026

Warm autoimmune haemolytic anaemia in Taiwan: A population-based study of epidemiology, treatment patterns, survival and healthcare utilisation (2017-2022).

British journal of haematology·2026

Clinical outcome and infectious complications in genetic and suspected genetic neutropenia: A report from the Canadian Inherited Marrow Failure Registry.

British journal of haematology·2026

SENIOR-IPI: An easily applicable prognostic index for first-line large B-cell lymphomas patients >80 years treated with curative intent.

British journal of haematology·2026

CALR-mutated myeloproliferative neoplasms: Refining molecular risk beyond the driver.

British journal of haematology·2026

RESOLVE to do better.

British journal of haematology·2026

A Novel Sequential Regimen of Efgartigimod and Telitacicept as Fast-Acting Treatment for Impeding Crisis of MuSK-MG.

Immunity, inflammation and disease·2026

Advances in non-invasive monitoring of drug delivery for neurodegenerative disorders.

Expert review of medical devices·2026

[Retracted] (‑)‑Epicatechin protects against myocardial ischemia‑induced cardiac injury via activation of the PTEN/PI3K/AKT pathway.

Molecular medicine reports·2026

Encorafenib plus binimetinib in patients with BRAF-mutated melanoma brain metastases: Results from the BECARE (GEM-2002) trial.

Neuro-oncology advances·2026

Advancing Membrane Technologies for Cancer Therapy and Environmental Health: Biomimetic Innovations, Smart Technologies, and Sustainable Translation.

ACS omega·2026

Rare Diseases as Engines of Biomedical Innovation: Lessons for Gene Therapy and Common Disease.

The Yale journal of biology and medicine·2026

Related Experiment Videos

Advances in the biology and treatment of myeloma

Related Concept Videos

Progression free survival of myeloma patients who become IFE-negative correlates with the detection of residual monoclonal free light chain (FLC) by mass spectrometry.

Combination of flow cytometry and functional imaging for monitoring of residual disease in myeloma.

Spatial genomic heterogeneity in multiple myeloma revealed by multi-region sequencing.

Carfilzomib resistance due to ABCB1/MDR1 overexpression is overcome by nelfinavir and lopinavir in multiple myeloma.

Prediction of outcome in newly diagnosed myeloma: a meta-analysis of the molecular profiles of 1905 trial patients.

Overexpression of EZH2 in multiple myeloma is associated with poor prognosis and dysregulation of cell cycle control.

Outcome heterogeneity in CALR-mutated myeloproliferative neoplasms.

Warm autoimmune haemolytic anaemia in Taiwan: A population-based study of epidemiology, treatment patterns, survival and healthcare utilisation (2017-2022).

Clinical outcome and infectious complications in genetic and suspected genetic neutropenia: A report from the Canadian Inherited Marrow Failure Registry.

SENIOR-IPI: An easily applicable prognostic index for first-line large B-cell lymphomas patients >80 years treated with curative intent.

CALR-mutated myeloproliferative neoplasms: Refining molecular risk beyond the driver.

RESOLVE to do better.

A Novel Sequential Regimen of Efgartigimod and Telitacicept as Fast-Acting Treatment for Impeding Crisis of MuSK-MG.

Advances in non-invasive monitoring of drug delivery for neurodegenerative disorders.

[Retracted] (‑)‑Epicatechin protects against myocardial ischemia‑induced cardiac injury via activation of the PTEN/PI3K/AKT pathway.

Encorafenib plus binimetinib in patients with BRAF-mutated melanoma brain metastases: Results from the BECARE (GEM-2002) trial.

Advancing Membrane Technologies for Cancer Therapy and Environmental Health: Biomimetic Innovations, Smart Technologies, and Sustainable Translation.

Rare Diseases as Engines of Biomedical Innovation: Lessons for Gene Therapy and Common Disease.

Related Experiment Videos

Advances in the biology and treatment of myeloma

Related Concept Videos

Related Articles